nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—SLC6A3—Gilles de la Tourette syndrome	0.854	1	CbGaD
Pseudoephedrine—SLC6A2—autonomic nervous system—Gilles de la Tourette syndrome	0.00827	0.131	CbGeAlD
Pseudoephedrine—MAOA—Clearance of dopamine—SLC6A3—Gilles de la Tourette syndrome	0.00812	0.107	CbGpPWpGaD
Pseudoephedrine—MAOA—Biogenic Amine Synthesis—HDC—Gilles de la Tourette syndrome	0.00644	0.0846	CbGpPWpGaD
Pseudoephedrine—NFATC1—nervous system—Gilles de la Tourette syndrome	0.00536	0.0849	CbGeAlD
Pseudoephedrine—NFATC1—central nervous system—Gilles de la Tourette syndrome	0.00517	0.0817	CbGeAlD
Pseudoephedrine—IL2—nervous system—Gilles de la Tourette syndrome	0.00491	0.0776	CbGeAlD
Pseudoephedrine—IL2—central nervous system—Gilles de la Tourette syndrome	0.00472	0.0747	CbGeAlD
Pseudoephedrine—NFATC1—brain—Gilles de la Tourette syndrome	0.0041	0.0649	CbGeAlD
Pseudoephedrine—IL2—brain—Gilles de la Tourette syndrome	0.00375	0.0593	CbGeAlD
Pseudoephedrine—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.00371	0.0487	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.00195	0.0256	CbGpPWpGaD
Pseudoephedrine—SLC6A3—midbrain—Gilles de la Tourette syndrome	0.00158	0.0249	CbGeAlD
Pseudoephedrine—SLC6A4—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.00149	0.0196	CbGpPWpGaD
Pseudoephedrine—SLC6A4—midbrain—Gilles de la Tourette syndrome	0.00145	0.0229	CbGeAlD
Pseudoephedrine—ADRB1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00135	0.0177	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.00135	0.0177	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00132	0.0173	CbGpPWpGaD
Pseudoephedrine—SLC6A3—nervous system—Gilles de la Tourette syndrome	0.0013	0.0205	CbGeAlD
Pseudoephedrine—TNF—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.00129	0.0169	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.00128	0.0168	CbGpPWpGaD
Pseudoephedrine—SLC6A3—central nervous system—Gilles de la Tourette syndrome	0.00125	0.0197	CbGeAlD
Pseudoephedrine—ADRB1—nervous system—Gilles de la Tourette syndrome	0.00123	0.0195	CbGeAlD
Pseudoephedrine—SLC6A4—nervous system—Gilles de la Tourette syndrome	0.00119	0.0188	CbGeAlD
Pseudoephedrine—ADRB1—central nervous system—Gilles de la Tourette syndrome	0.00118	0.0187	CbGeAlD
Pseudoephedrine—Phenylpropanolamine—SLC6A3—Gilles de la Tourette syndrome	0.00117	0.18	CrCbGaD
Pseudoephedrine—MAOA—midbrain—Gilles de la Tourette syndrome	0.00117	0.0185	CbGeAlD
Pseudoephedrine—ADRB1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00115	0.0151	CbGpPWpGaD
Pseudoephedrine—SLC6A4—central nervous system—Gilles de la Tourette syndrome	0.00114	0.0181	CbGeAlD
Pseudoephedrine—ADRB2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00113	0.0148	CbGpPWpGaD
Pseudoephedrine—ADRB1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00112	0.0147	CbGpPWpGaD
Pseudoephedrine—ADRB2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00109	0.0144	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00109	0.0143	CbGpPWpGaD
Pseudoephedrine—SLC6A2—nervous system—Gilles de la Tourette syndrome	0.00105	0.0165	CbGeAlD
Pseudoephedrine—Phentermine—SLC6A3—Gilles de la Tourette syndrome	0.00105	0.16	CrCbGaD
Pseudoephedrine—ADRB1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00104	0.0137	CbGpPWpGaD
Pseudoephedrine—ADRB2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00102	0.0134	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00102	0.0133	CbGpPWpGaD
Pseudoephedrine—SLC6A2—central nervous system—Gilles de la Tourette syndrome	0.00101	0.0159	CbGeAlD
Pseudoephedrine—Dextroamphetamine—SLC6A3—Gilles de la Tourette syndrome	0.000997	0.153	CrCbGaD
Pseudoephedrine—SLC6A3—brain—Gilles de la Tourette syndrome	0.000991	0.0157	CbGeAlD
Pseudoephedrine—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.000972	0.0154	CbGeAlD
Pseudoephedrine—ADRB1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000968	0.0127	CbGpPWpGaD
Pseudoephedrine—MAOA—nervous system—Gilles de la Tourette syndrome	0.000964	0.0152	CbGeAlD
Pseudoephedrine—ADRB2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000947	0.0124	CbGpPWpGaD
Pseudoephedrine—ADRB1—brain—Gilles de la Tourette syndrome	0.00094	0.0149	CbGeAlD
Pseudoephedrine—ADRB1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00094	0.0123	CbGpPWpGaD
Pseudoephedrine—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000936	0.0148	CbGeAlD
Pseudoephedrine—ADRA1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000932	0.0122	CbGpPWpGaD
Pseudoephedrine—MAOA—central nervous system—Gilles de la Tourette syndrome	0.000928	0.0147	CbGeAlD
Pseudoephedrine—ADRB2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000919	0.0121	CbGpPWpGaD
Pseudoephedrine—SLC6A4—brain—Gilles de la Tourette syndrome	0.000908	0.0144	CbGeAlD
Pseudoephedrine—ADRA1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000905	0.0119	CbGpPWpGaD
Pseudoephedrine—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000899	0.0142	CbGeAlD
Pseudoephedrine—ADRB1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000875	0.0115	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000866	0.0114	CbGpPWpGaD
Pseudoephedrine—ADRB2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000856	0.0112	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.000843	0.0111	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000841	0.011	CbGpPWpGaD
Pseudoephedrine—Amphetamine—SLC6A3—Gilles de la Tourette syndrome	0.000804	0.123	CrCbGaD
Pseudoephedrine—SLC6A2—brain—Gilles de la Tourette syndrome	0.000799	0.0126	CbGeAlD
Pseudoephedrine—ADRA1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000783	0.0103	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.000783	0.0103	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00076	0.00999	CbGpPWpGaD
Pseudoephedrine—Methamphetamine—SLC6A3—Gilles de la Tourette syndrome	0.000745	0.114	CrCbGaD
Pseudoephedrine—ADRA1A—brain—Gilles de la Tourette syndrome	0.000743	0.0118	CbGeAlD
Pseudoephedrine—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000739	0.0117	CbGeAlD
Pseudoephedrine—MAOA—brain—Gilles de la Tourette syndrome	0.000737	0.0117	CbGeAlD
Pseudoephedrine—Atomoxetine—SLC6A3—Gilles de la Tourette syndrome	0.000733	0.112	CrCbGaD
Pseudoephedrine—ADRB1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000729	0.00958	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000728	0.00956	CbGpPWpGaD
Pseudoephedrine—ADRB2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000714	0.00937	CbGpPWpGaD
Pseudoephedrine—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000712	0.0113	CbGeAlD
Pseudoephedrine—ADRA1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000708	0.0093	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000707	0.00928	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000658	0.00864	CbGpPWpGaD
Pseudoephedrine—ADRB1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000613	0.00805	CbGpPWpGaD
Pseudoephedrine—ADRB2—Arf6 signaling events—MET—Gilles de la Tourette syndrome	0.000607	0.00797	CbGpPWpGaD
Pseudoephedrine—ADRB2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0006	0.00788	CbGpPWpGaD
Pseudoephedrine—Amphetamine—DRD2—Gilles de la Tourette syndrome	0.000598	0.0917	CrCbGaD
Pseudoephedrine—ADRA1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00059	0.00775	CbGpPWpGaD
Pseudoephedrine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000573	0.00906	CbGeAlD
Pseudoephedrine—ADRA2A—brain—Gilles de la Tourette syndrome	0.000565	0.00894	CbGeAlD
Pseudoephedrine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000551	0.00872	CbGeAlD
Pseudoephedrine—ADRA2A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000548	0.0072	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.000528	0.00694	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.0005	0.00657	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000496	0.00652	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000486	0.00638	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000461	0.00605	CbGpPWpGaD
Pseudoephedrine—SLC6A4—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.000443	0.00582	CbGpPWpGaD
Pseudoephedrine—CYP2D6—brain—Gilles de la Tourette syndrome	0.000438	0.00692	CbGeAlD
Pseudoephedrine—Atomoxetine—HTR2A—Gilles de la Tourette syndrome	0.000421	0.0647	CrCbGaD
Pseudoephedrine—SLC6A2—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.000381	0.005	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000373	0.00489	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000362	0.00475	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000337	0.00442	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.000317	0.00416	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000289	0.0038	CbGpPWpGaD
Pseudoephedrine—MAOA—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000282	0.00371	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000261	0.00343	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000254	0.00333	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00025	0.00328	CbGpPWpGaD
Pseudoephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00024	0.00315	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000237	0.00311	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000237	0.00311	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000236	0.0031	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00023	0.00302	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000222	0.00292	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000217	0.00286	CbGpPWpGaD
Pseudoephedrine—MAOA—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000216	0.00284	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000216	0.00283	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000214	0.00282	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000211	0.00277	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000201	0.00264	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000197	0.00258	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00019	0.0025	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000186	0.00245	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000185	0.00243	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000181	0.00237	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00018	0.00236	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00018	0.00236	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000175	0.0023	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000175	0.00229	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000172	0.00226	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000168	0.00221	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000167	0.00219	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000166	0.00218	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000165	0.00217	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000163	0.00214	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000163	0.00214	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000162	0.00213	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000161	0.00211	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—HDC—Gilles de la Tourette syndrome	0.000156	0.00205	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000154	0.00202	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000151	0.00198	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00015	0.00197	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00015	0.00197	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00015	0.00196	CbGpPWpGaD
Pseudoephedrine—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000147	0.00194	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000145	0.0019	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000143	0.00188	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000142	0.00186	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000141	0.00185	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000141	0.00185	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00014	0.00184	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000139	0.00183	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000139	0.00183	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000138	0.00181	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000138	0.00181	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000136	0.00179	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000132	0.00173	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000131	0.00172	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000129	0.0017	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000128	0.00168	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000127	0.00166	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000122	0.0016	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000121	0.00158	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000118	0.00155	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000117	0.00154	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000114	0.0015	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000114	0.0015	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000109	0.00143	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000106	0.00139	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000106	0.00139	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000106	0.00139	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000105	0.00138	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	0.000105	0.00137	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	9.86e-05	0.00129	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.76e-05	0.00128	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	9.18e-05	0.00121	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.07e-05	0.00119	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.98e-05	0.00118	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8.87e-05	0.00117	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—MET—Gilles de la Tourette syndrome	8.85e-05	0.00116	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.19e-05	0.00108	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.02e-05	0.00105	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.96e-05	0.00104	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.78e-05	0.00102	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.44e-05	0.000977	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.43e-05	0.000976	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.41e-05	0.000973	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.28e-05	0.000956	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.25e-05	0.000952	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.22e-05	0.000949	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.07e-05	0.000928	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.9e-05	0.000907	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	6.81e-05	0.000895	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.73e-05	0.000884	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.63e-05	0.000871	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.58e-05	0.000865	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.44e-05	0.000845	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.16e-05	0.000809	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.02e-05	0.000791	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6e-05	0.000787	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.98e-05	0.000785	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.85e-05	0.000768	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.59e-05	0.000735	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.57e-05	0.000732	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.45e-05	0.000715	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.43e-05	0.000713	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.19e-05	0.000682	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.08e-05	0.000667	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.06e-05	0.000664	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.71e-05	0.000619	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.61e-05	0.000606	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.4e-05	0.000577	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.3e-05	0.000565	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.27e-05	0.00056	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.2e-05	0.000552	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.17e-05	0.000548	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.98e-05	0.000522	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.9e-05	0.000512	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.89e-05	0.000511	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.81e-05	0.000501	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.56e-05	0.000467	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.54e-05	0.000465	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.45e-05	0.000453	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.3e-05	0.000434	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.22e-05	0.000422	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.21e-05	0.000421	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.99e-05	0.000393	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.78e-05	0.000366	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.72e-05	0.000358	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.25e-05	0.000296	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.09e-05	0.000275	CbGpPWpGaD
